Angiotensin II as a linking factor in cardiovascular disease enhanced cancer growth

2 September 2024 (13:45 - 13:55)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Benji Van Berlo

University of Antwerp, Antwerp (Belgium)

5 More presentations in this session

Presentation thumbnail

Artificial intelligence applied to electrocardiographic images for the risk stratification of cancer therapeutics-related cardiac dysfunction

Doctor E. Oikonomou (New Haven, US)

Abstract Slides Video

Presentation thumbnail

Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry

Doctor B. Huang (Chongqing, CN)

Abstract Slides Video

Presentation thumbnail

Immune-checkpoint myocarditis phenotype when using systematic troponin surveillance in cancer patients.

Doctor F. Cribari (Rome, IT)

Abstract Slides Video

Presentation thumbnail

Correlative study to assess the predictive power of the ICOS HF calculator in the prediction of development of HER-2 antagonist induced cardiac dysfunction in a single center in Saudi Arabia in 2023

Doctor M. Al Qaseer (Dammam, SA)

Abstract Slides Video

Presentation thumbnail

Transcatheter mitral edge-to-edge repair in patients with prior cancer diagnosis

Doctor R. Gonzalez-Manzanares (Cordoba, ES)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiovascular risk of cancer therapy

The Event

Event poster

ESC Congress 2024

2 September 2024 13:45 CET

You may be interested in

Congress Presentation

Human heart-tumor interaction in ischemic / failing heart is mediated by cardiac mesenchymal stromal cells

Congress Presentation

Understanding the impact of heart failure treatment on cancer growth

Congress Presentation

Understanding the impact of heart failure treatment on cancer growth

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources